Aug 13 2020 23 mins
This week, Mike and Jeremy hear from Dr. Elijah Stommel, a neurologist at Dartmouth-Hitchcock Health and a professor of neurology at the Geisel School of Medicine at Dartmouth. Dr. Stommel walks us through the connection between exposure to blue-green algae toxins and development of ALS, and provides insight on continuing to do ALS research during the COVID-19 pandemic.
For more information on Dr. Stommel, check out https://www.dartmouth-hitchcock.org/findaprovider/provider/192/Elijah-W-Stommel
Learn more about Dr. Stommel’s work on blue-green algae here: https://www.als.org/research/research-we-fund/funded-grants
Check out this Q&A with Dr. Stommel about environmental risk factors: https://geiselmed.dartmouth.edu/news/2016/link-between-environmental-toxin-and-als-grows-stronger/
For more information on enrollment in the Healey ALS Platform Trial, read https://www.als.org/stories-news/healey-als-platform-trial-enrolls-first-participants
This episode was produced by Garrett Tiedemann and is brought to you by The ALS Association’s national office and the Association’s Minnesota/North Dakota/South Dakota Chapter.